lawsuit against semaglutide Ozempic Ozempic Lawsuit Statute Of Limitations

Take a deep breath

Doctors say the restrictions can also affect diabetes patients who need to switch from other GLP-1 drugs or adjust doses for treatment reasons

PMID: 38302593 | doi:10.1038/s41366-024-01473-y Sanyal AJ et al

The reason I dont like this is because, in my experience, a lot of people have questions about the medication and treatment, and want to speak with a doctor before they commit

But the use of GLP-1 receptor agonists for weight loss has increased from 3.7% in 2019 to 16.5% in 2024, according to FAIR Health data on all commercially insured adult patients

A study from the University of Michigan Medical School in Ann Arbor examined US data between 2020 and 2023